Skip to content

PENG VERSUS FIB

COMPARISON OF THE NOVEL PENG (PERICAPSULAR NERVE GROUP) BLOCK VERSUS FASCIA ILIACA BLOCK (FIB) IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230809059091N2
Enrollment
150
Registered
2023-08-16
Start date
2023-08-09
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain with total hip arthroplasty due to osteoarthritis. Osteoarthritis of hip

Interventions

Intervention 1: Intervention group: Group F (Fascia iliac block group) will receive the block pre-operatively in the operating room with the patient unaware of the block performed by a consultant anes

Sponsors

CMH Rahim Yar Khan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Included all ASA-II (American society of Anaesthesiologists) male and female patients above the age of fifty years Requiring total hip arthroplasty (THA) due to advanced osteoarthritis of the hip joint.

Exclusion criteria

Exclusion criteria: Excluded patients with major cardiac or respiratory debility, metastatic bone disease, allergy to drugs used for the block, bleeding diathesis, coagulation defects, patients with patchy or failed block after administration and patients not willing to be included in the study. Metastatic bone disease Allergy to the drugs used in the block (lignocaine) Bleeding diathesis and coagulation disorders Patients with patchy or failed block after administration Patients not willing to be included in the study

Design outcomes

Primary

MeasureTime frame
Mean time for first dose of rescue analgesia and mean time to patient mobilization. Timepoint: Within 12 hours post-surgery. Method of measurement: Standard Visual Analog scale for pain assessment.

Countries

Pakistan

Contacts

Public ContactNabeel Butt

Combined Military Hospital Rahim Yar Khan

nabeel4allz@gmail.com+92 313 5969696

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026